vs
Phillips Edison & Company, Inc.（PECO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Phillips Edison & Company, Inc.的1.0倍（$197.9M vs $190.7M），Phillips Edison & Company, Inc.净利率更高（17.4% vs 6.7%，领先10.7%），REPLIGEN CORP同比增速更快（13.6% vs 7.0%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 8.7%）
联合爱迪生公司（通常简称Con Edison或ConEd）是总部位于纽约市的能源企业，为美国规模最大的投资者所有能源公司之一。截至2024年，该公司年营收约152.6亿美元，总资产超700亿美元，通过旗下子公司为客户提供多元化的能源相关产品与服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PECO vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.0倍
$190.7M
营收增速更快
RGEN
高出6.7%
7.0%
净利率更高
PECO
高出10.7%
6.7%
两年增速更快
RGEN
近两年复合增速
8.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $190.7M | $197.9M |
| 净利润 | $33.2M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 30.5% | 9.0% |
| 净利率 | 17.4% | 6.7% |
| 营收同比 | 7.0% | 13.6% |
| 净利润同比 | 15.1% | 143.9% |
| 每股收益（稀释后） | $0.24 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PECORGEN
| Q1 26 | $190.7M | — | ||
| Q4 25 | $187.9M | $197.9M | ||
| Q3 25 | $182.7M | $188.8M | ||
| Q2 25 | $177.8M | $182.4M | ||
| Q1 25 | $178.3M | $169.2M | ||
| Q4 24 | $173.0M | $174.1M | ||
| Q3 24 | $165.5M | $154.9M | ||
| Q2 24 | $161.5M | $154.1M |
净利润PECORGEN
| Q1 26 | $33.2M | — | ||
| Q4 25 | $47.5M | $13.3M | ||
| Q3 25 | $24.7M | $14.9M | ||
| Q2 25 | $12.8M | $14.9M | ||
| Q1 25 | $26.3M | $5.8M | ||
| Q4 24 | $18.1M | $-30.3M | ||
| Q3 24 | $11.6M | $-654.0K | ||
| Q2 24 | $15.3M | $3.3M |
毛利率PECORGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% |
营业利润率PECORGEN
| Q1 26 | 30.5% | — | ||
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | 1.0% |
净利率PECORGEN
| Q1 26 | 17.4% | — | ||
| Q4 25 | 25.3% | 6.7% | ||
| Q3 25 | 13.5% | 7.9% | ||
| Q2 25 | 7.2% | 8.2% | ||
| Q1 25 | 14.8% | 3.4% | ||
| Q4 24 | 10.5% | -17.4% | ||
| Q3 24 | 7.0% | -0.4% | ||
| Q2 24 | 9.5% | 2.2% |
每股收益（稀释后）PECORGEN
| Q1 26 | $0.24 | — | ||
| Q4 25 | $0.38 | $0.24 | ||
| Q3 25 | $0.20 | $0.26 | ||
| Q2 25 | $0.10 | $0.26 | ||
| Q1 25 | $0.21 | $0.10 | ||
| Q4 24 | $0.16 | $-0.55 | ||
| Q3 24 | $0.09 | $-0.01 | ||
| Q2 24 | $0.12 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.1M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $2.3B | $2.1B |
| 总资产 | $5.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PECORGEN
| Q1 26 | $3.1M | — | ||
| Q4 25 | $3.5M | $767.6M | ||
| Q3 25 | $4.1M | $748.7M | ||
| Q2 25 | $5.6M | $708.9M | ||
| Q1 25 | $5.5M | $697.2M | ||
| Q4 24 | $4.9M | $757.4M | ||
| Q3 24 | $6.4M | $784.0M | ||
| Q2 24 | $7.1M | $809.1M |
总债务PECORGEN
| Q1 26 | — | — | ||
| Q4 25 | $2.4B | $542.2M | ||
| Q3 25 | $2.4B | $537.9M | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.1B | $525.6M | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.0B | — |
股东权益PECORGEN
| Q1 26 | $2.3B | — | ||
| Q4 25 | $2.3B | $2.1B | ||
| Q3 25 | $2.3B | $2.1B | ||
| Q2 25 | $2.3B | $2.1B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.3B | $2.0B | ||
| Q3 24 | $2.2B | $2.0B | ||
| Q2 24 | $2.3B | $2.0B |
总资产PECORGEN
| Q1 26 | $5.4B | — | ||
| Q4 25 | $5.3B | $2.9B | ||
| Q3 25 | $5.3B | $2.9B | ||
| Q2 25 | $5.3B | $2.9B | ||
| Q1 25 | $5.2B | $2.9B | ||
| Q4 24 | $5.0B | $2.8B | ||
| Q3 24 | $5.0B | $2.8B | ||
| Q2 24 | $4.9B | $2.9B |
负债/权益比PECORGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.04× | 0.26× | ||
| Q3 25 | 1.05× | 0.26× | ||
| Q2 25 | 1.04× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 0.91× | 0.27× | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.90× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.6M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | 12.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.67× | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流PECORGEN
| Q1 26 | $55.6M | — | ||
| Q4 25 | $348.1M | $25.7M | ||
| Q3 25 | $95.4M | $48.1M | ||
| Q2 25 | $96.1M | $28.6M | ||
| Q1 25 | $60.5M | $15.0M | ||
| Q4 24 | $334.7M | $39.2M | ||
| Q3 24 | $109.1M | $49.3M | ||
| Q2 24 | $78.5M | $42.2M |
自由现金流PECORGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M |
自由现金流率PECORGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% |
资本支出强度PECORGEN
| Q1 26 | 12.6% | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% |
现金转化率PECORGEN
| Q1 26 | 1.67× | — | ||
| Q4 25 | 7.33× | 1.93× | ||
| Q3 25 | 3.87× | 3.23× | ||
| Q2 25 | 7.52× | 1.92× | ||
| Q1 25 | 2.30× | 2.57× | ||
| Q4 24 | 18.45× | — | ||
| Q3 24 | 9.40× | — | ||
| Q2 24 | 5.14× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PECO
| Rental income | $186.3M | 98% |
| Fees and management income | $3.4M | 2% |
RGEN
暂无分部数据
